Conference attendance
Pharming Group to participate in February investor conference
Pharming Group N.V. announces that Pharming’s management will participate in the following investor conference in the month of February:
- Oppenheimer 35th Annual Healthcare Life Sciences Conference, Virtual, February 11-12, 2025
Sijmen de Vries, Chief Executive Officer and Anurag Relan, Chief Medical Officer, will present on Wednesday, February 12 at 08:40 ET/14:40 CET. (view live webcast)
For more information about this conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Oppenheimer representative.